Title:
ハンチントン病の症状の治療のための3,11B-シス-ジヒドロテトラベナジンの使用
Document Type and Number:
Japanese Patent JP2009501202
Kind Code:
A
Abstract:
The invention provides 3,11b- cis -dihydrotetrabenazine for use in halting or slowing the progress of one or more symptoms of Huntington's disease in a patient, and more particularly a symptom selected from involuntary movements such as involuntary chorea, tremors and twitches, and degeneration in gait.
Inventors:
Robert, tridget
Thierry, Philo
Thierry, Philo
Application Number:
JP2008520952A
Publication Date:
January 15, 2009
Filing Date:
July 13, 2006
Export Citation:
Assignee:
CAMBRIDGE LABORATORIES (IRELAND) LIMITED
International Classes:
A61K31/4738; A61P25/14; C07D455/06
Foreign References:
| US2830993A | 1958-04-15 | |||
| US2843591A | 1958-07-15 | |||
| US6087376A | 2000-07-11 |
Other References:
JPN5007001887; ＨＥＬＶＥＴＩＣＡ ＣＨＩＭＩＣＡ ＡＣＴＡ Ｖ４１, 1958, Ｐ１７９３-１８０６
JPN5007001886; ＥＵＲＯＰＥＡＮ ＪＯＵＮＡＬ ＯＦ ＰＨＡＲＭＡＣＯＬＯＧＹ Ｖ２７８ Ｎ３, 1995, Ｐ２４９-２５２
JPN5007001885; ＣＨＩＲＡＬＩＴＹ Ｖ９ Ｎ１, 1997, Ｐ５９-６２
JPN5007001886; ＥＵＲＯＰＥＡＮ ＪＯＵＮＡＬ ＯＦ ＰＨＡＲＭＡＣＯＬＯＧＹ Ｖ２７８ Ｎ３, 1995, Ｐ２４９-２５２
JPN5007001885; ＣＨＩＲＡＬＩＴＹ Ｖ９ Ｎ１, 1997, Ｐ５９-６２
Attorney, Agent or Firm:
Kenji Yoshitake
Yukitaka Nakamura
Konno Akio
Noritaka Yokota
Yukitaka Nakamura
Konno Akio
Noritaka Yokota